Novelwise Pharmaceuticals Announces Collaboration with U.S. Patient Advocacy Group A Cure In Sight (ACIS) to Advance Ocular Melanoma Research

Novelwise Pharmaceuticals is honored to announce its collaboration with the U.S. patient advocacy organization A Cure In Sight (ACIS) in August 2025.

This partnership underscores our mission to expand treatment options for patients living with ocular melanoma, a rare cancer with significant unmet medical needs. Through this collaboration, Novelwise contributes to the global effort of developing innovative therapies and increasing awareness of ocular melanoma.

Together with ACIS, we aim to provide patients and physicians with more choices and greater hope. For more information on ACIS activities and the latest updates, please visit their official website: ACIS Website:

1. Ocular Melanoma Uveal Melanoma, Worlds Largest Info Source - A Cure In Sight™ - Ocular Melanoma
2. UVEAL MELANOMA Clinical Trials SUMMARY